Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Drug Modeling Softwares Market contains market size and forecasts of Drug Modeling Softwares in Global, including the following market information:
- Global Drug Modeling Softwares Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Drug Modeling Softwares market was valued at 7678.5 million in 2021 and is projected to reach US$ 13560 million by 2028, at a CAGR of 8.5% during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Database Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Drug Modeling Softwares include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Drug Modeling Softwares companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Modeling Softwares Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Type, 2021 (%)
Global Drug Modeling Softwares Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Application, 2021 (%)
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modelling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
Global Drug Modeling Softwares Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Modeling Softwares Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Drug Modeling Softwares revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Drug Modeling Softwares revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- JSR Corporation(Crown Bioscience)
- Chemical Computing Group ULC
- Nimbus Therapeutics
- Schrodinger, Inc
- Genedata AG
- Biognos AB
- Compugen Ltd
- Dassault Systemes
- Acellera
- Instem(Leadscope)
Industry Market Size
